Five Star Home Hospice 1028 N Lake Ave, Suite 106, Pasadena, CA, 91104 | |
(626) 791-1764 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
Using restricted-access Census data, a new study examines a quarter-million households on a block-by-block basis to yield new results about the correlation between household attributes and school quality.
Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.
Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.
› Verified 9 days ago
Name | Five Star Home Hospice |
---|---|
Location | 1028 N Lake Ave, Suite 106, Pasadena, California |
Hospice ID | 551631 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | The Joint Commission (TJC) |
SSA county code | 200 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
Using restricted-access Census data, a new study examines a quarter-million households on a block-by-block basis to yield new results about the correlation between household attributes and school quality.
Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.
Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.
› Verified 9 days ago
NPI Number | 1730206038 |
Organization Name | Five Star Home Hospice, Inc. |
Address | 1028 N Lake Ave Ste 106 Pasadena, California, 91104 |
Phone Number | (626)791-1764 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
Using restricted-access Census data, a new study examines a quarter-million households on a block-by-block basis to yield new results about the correlation between household attributes and school quality.
Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.
Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.
› Verified 9 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 95.7 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 98.9 | 97.3 |
Patients who got timely treatment for shortness of breath | 97.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 52.9 | 93.3 |
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
Using restricted-access Census data, a new study examines a quarter-million households on a block-by-block basis to yield new results about the correlation between household attributes and school quality.
Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.
Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.
› Verified 9 days ago
Home Health Aides | 2 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 3 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 3 |
Total Employees | 11 |
---|
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
Using restricted-access Census data, a new study examines a quarter-million households on a block-by-block basis to yield new results about the correlation between household attributes and school quality.
Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.
Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.
› Verified 9 days ago
Others | 1 |
Total Volunteers | 1 |
---|
News Archive
Alios BioPharma, Inc. today announced that it has begun oral dosing of ALS-8176 in a Phase 1 clinical trial. ALS-8176 is a structurally novel, anti-respiratory syncytial virus (RSV) nucleoside analog that is being developed for the treatment of acute RSV infection.
Using restricted-access Census data, a new study examines a quarter-million households on a block-by-block basis to yield new results about the correlation between household attributes and school quality.
Darla Shine has recently joined anti-vaccination campaigners by claiming that having measles as a child could protect against cancer in later life.
Ovarian cancer treatment, health care reform, the impact of obesity on gynecologic health and the delivery of high quality gynecologic cancer care highlight the Society of Gynecologic Oncology's (SGO) 44th Annual Meeting on Women's Cancer March 9-12 in Los Angeles.
› Verified 9 days ago
Vna Of Greater Los Angeles, Inc Location: 2826 E Foothill Blvd Suite 101, Pasadena, California, 91107 Phone: (626) 791-1764 |
Mission Hospice Location: 2555 East Colorado Blvd Suite 301, Pasadena, California, 91107 Phone: (626) 791-1764 |
Hospice Angels Location: 408 S Rosemead Blvd #5, Pasadena, California, 91107 Phone: (626) 791-1764 |
Assurance Hospice, Inc Location: 40 N Altadena Drive, Suite 102, Pasadena, California, 91107 Phone: (626) 791-1764 |